1-20 of 79
Loretta Nastoupil
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study

Mazyar Shadman, Nancy L. Bartlett, Matthew Matasar, Stephen J. Schuster, Sarit E. Assouline, Laurie H. Sehn, John Kuruvilla, Pratyush Giri, Chan Y. Cheah, Sascha Dietrich, Keith Fay, Matthew Ku, Loretta Nastoupil, Michael C. Wei, Shen Yin, Connie Y. Ma, Samuel Tracy, Antonia Kwan, Elicia Penuel, L. Elizabeth Budde
Journal: Blood
Blood (2024) 144 (Supplement 1): 4407.
https://doi.org/10.1182/blood-2024-197897
Published: 2024
Journal Articles

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Patrizia Mondello, Brianna J Negaard, Luca Arcaini, Joshua Tobin, Loic Chartier, Brian K. Link, Andrew L. Feldman, Dai Chihara, Carla Casulo, Anne Ségolène Cottereau, Luca Guerra, Joshua Olson, Jason T Romancik, Sara Haddadi, Harrison Black, Thomas Trevis, Eric Mou, Tsz Hung Tong, Kamilia Moalem, Anna M. Johnston, Paul J. Hampel, Jeffrey Johnson, Steinepreis Elizabeth, Pinguang Yang, Serena Kosciejew, Goodall Elizabeth, Kate Manos, Chan Y. Cheah, Ross Salvaris, Thomas M. Habermann, Peter Martin, Brad S. Kahl, Grzegorz S. Nowakowski, Georgina Hodges, Loretta Nastoupil, Dipti Talaulikar, Judith Trotman, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos, Richard Burack, Stefano Luminari, Franck Morschhauser, Stephen M. Ansell, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 3007.
https://doi.org/10.1182/blood-2024-202088
Published: 2024
Journal Articles

Golcadomide (GOLCA) ± Rituximab (RTX) Demonstrates Durable Efficacy and Is Well Tolerated in Patients (pts) with Relapsed/Refractory Follicular Lymphoma (R/R FL): Updated Results from the Phase 1/2 CC-99282-NHL-001 Study

Julio C. Chavez, Guilherme Fleury Perini, Loretta Nastoupil, Judit Mészáros Joergensen, Pierre Bories, Bijou Fontanet, Pier Luigi Zinzani, Javier Munoz, Daniel Morillo Giles, Cecilia Carpio, Abel Costa, Won Seog Kim, Parth Rao, Bérengère de Moucheron, Yang Gang, Carla Guarinos, Akshay Sudhindra, Michael Pourdehnad, Jean-Marie Michot
Journal: Blood
Blood (2024) 144 (Supplement 1): 3018.
https://doi.org/10.1182/blood-2024-203131
Published: 2024
Journal Articles

Real-World Effectiveness of Tafasitamab (Tafa) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the United States

Kimberly Saverno, Loretta Nastoupil, Bruce Feinberg, John Galvin, Prathamesh Pathak, Theresa Amoloja, Danielle Gentile, Parisa Asgarisabet, Narendranath Epperla
Journal: Blood
Blood (2024) 144 (Supplement 1): 2375.
https://doi.org/10.1182/blood-2024-193264
Published: 2024
Journal Articles

Real-World Predictors of Financial Toxicity in Patients with Lymphoma

Syeda A Mina, Katherine E Smith, Ashley D Hickman, Melissa C. Larson, Brianna J Negaard, Brittany C Kimball, Matthew J. Maurer, Kathleen J Yost, Grzegorz S. Nowakowski, Izidore S. Lossos, Peter Martin, Jonathon B. Cohen, Brian K. Link, Brad S. Kahl, Loretta Nastoupil, James R. Cerhan, Christopher R. Flowers, Amylou C Dueck, Annalynn M Williams, Carla Casulo, Carrie A Thompson, Urshila Durani
Journal: Blood
Blood (2024) 144 (Supplement 1): 3754.
https://doi.org/10.1182/blood-2024-201896
Published: 2024
Journal Articles

Treatment Patterns and Real World Outcomes with Clinical Trials for Patients with Follicular Lymphoma across Lines of Therapy

Neha Akkad, Amy Ayers, Kumudha Balakrishnan, Loretta Nastoupil, Dai Chihara, Luis Malpica, Paolo Strati, Ziyi Li, Christopher R. Flowers
Journal: Blood
Blood (2024) 144 (Supplement 1): 4396.
https://doi.org/10.1182/blood-2024-201804
Published: 2024
Journal Articles

Vulnerable Elders Survey (VES-13) and Longitudinal Analysis of Quality of Life in Indolent Non-Hodgkin Lymphoma: A Multi-Institutional Prospective Cohort Study

Mazie Tsang, Brie N Noble, Carla Casulo, Carrie A Thompson, Allison C. Rosenthal, Dai Chihara, Eric Mou, Urshila Durani, Annalynn M Williams, Michelle A.T. Hildebrandt, Kathleen J Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Andrew L. Feldman, David L. Jaye, Jon Tilburt, Ajay Major, Talal Hilal, Yucai Wang, Amber Koehler, Timothy G. Call, Sameer A. Parikh, Javier L. Munoz, Gita Thanarajasingam, Loretta Nastoupil, Grzegorz S. Nowakowski, Jonathon B. Cohen, Thomas M. Habermann, Christopher Strouse, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Amylou C Dueck
Journal: Blood
Blood (2024) 144 (Supplement 1): 2345.
https://doi.org/10.1182/blood-2024-210594
Published: 2024
Journal Articles

Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Transcend FL 2-Year Follow-up

Loretta Nastoupil, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martín García-Sancho, Juan Luis Reguera, John Kuruvilla, Ulrich Jaeger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad S. Kahl, Herve Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S. Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan P Skarbnik, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Grace Shih Hui Kao, Min Vedal, Rina Nishii, Jessica Papuga, Jinender Kumar, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 4387.
https://doi.org/10.1182/blood-2024-198509
Published: 2024
Journal Articles

Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma

Swetha Kambhampati, Reid W. Merryman, Yan Wang, Charles Gaulin, Evandro Bezerra, Timothy Voorhees, Madhav R Seshadri, Ayo S Falade, Alma Habib, Amy A. Ayers, Megumi Bailey, Annette Brown, Neil Bailey, Krish Patel, Charalambos Andreadis, Adam S Kittai, Caron A. Jacobson, Joycelynne Michelle Palmer, Stephen J. Forman, Loretta Nastoupil, Lihua E. Budde
Journal: Blood
Blood (2024) 144 (Supplement 1): 524.
https://doi.org/10.1182/blood-2024-198749
Published: 2024
Journal Articles

Subsets of Follicular Lymphoma (FL) 3B Have Divergent Biological Behavior and Clinical Outcome: Results from the Prospective Multicenter MER and LEO Cohorts

Patrizia Mondello, Brianna J Negaard, Andrew L. Feldman, Brian K. Link, Carla Casulo, Dai Chihara, David A Russler-Germain, Jason Romancik, Caitlin Gribbin, Sara Haddadi, Eric Mou, Ivana N. Micallef, Patrick B. Johnston, Anne J. Novak, Yucai Wang, Rebecca L. King, Thomas M. Habermann, Peter Martin, Grzegorz S. Nowakowski, Loretta Nastoupil, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos, Richard Burack, Matthew J. Maurer, Stephen M. Ansell
Journal: Blood
Blood (2024) 144 (Supplement 1): 1629.
https://doi.org/10.1182/blood-2024-194681
Published: 2024
Journal Articles

Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with R-GemOx: A Multi-Center Retrospective Cohort Study

Samuel Yamshon, Jean L. Koff, Melissa C. Larson, Brad S. Kahl, Carla Casulo, Izidore S. Lossos, Sara Haddadi, Michele D. Stanchina, Dai Chihara, Amy A. Ayers, Thomas M. Habermann, Yucai Wang, Arushi Khurana, Grzegorz S. Nowakowski, Tanner W Reicks, Umar Farooq, Brian K. Link, Jonathon B. Cohen, Peter Martin, Jia Li, Ashwini Shewade, Connie Lee Batlevi, Andrea Lo-Rossi, David Fox, Anthony Masaquel, Yong Mun, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Loretta Nastoupil
Journal: Blood
Blood (2024) 144 (Supplement 1): 3093.
https://doi.org/10.1182/blood-2024-208111
Published: 2024
Journal Articles

Impact of Pre-Existing Mental Health Disorders (MHD) on CAR T-Cell Therapy Outcomes in Patients with Large B-Cell Lymphoma

Sushanth Gouni, Anath Lionel, Lei Feng, Charles Gaulin, Tejaswini Reddy, Amrit S. Gonugunta, Victoria Chu, Taylor Hopper, Amy A. Ayers, Inimfon Jackson, Ajlan Al Zaki, Michelle A.T. Hildebrandt, Loretta Nastoupil, Dai Chihara, Chijioke Nze, Jeremy Ramdial, Elizabeth J. Shpall, Jason R. Westin, Christopher R. Flowers, Paolo Strati, Sattva S. Neelapu, Rachel Lynn, Sairah Ahmed
Journal: Blood
Blood (2024) 144 (Supplement 1): 4508.
https://doi.org/10.1182/blood-2024-198053
Published: 2024
Journal Articles

Impact of Pre-Treatment Liver-Related Factors on Clinical Outcomes after CAR T-Cell Therapy for Lymphoma

Anath Lionel, Sushanth Gouni, Lei Feng, Charles Gaulin, Amrit S. Gonugunta, Turcin Saridogan, Michelly Abreu, Jaimole Varghese, Karla Ow, Minifrida Santiago, Ajlan Al Zaki, Sherry Adkins, Amy A. Ayers, Misha Hawkins, Partow Kebriaei, Elizabeth J. Shpall, Swaminathan P Iyer, Preetesh Jain, Michael Wang, Christopher R. Flowers, Jeremy Ramdial, Loretta Nastoupil, Jason R. Westin, Paolo Strati, Sattva S. Neelapu, Deyali Chatterjee, Sairah Ahmed
Journal: Blood
Blood (2024) 144 (Supplement 1): 4506.
https://doi.org/10.1182/blood-2024-207616
Published: 2024
Journal Articles

Three-Factor Prediction Model for Grade 2+ Cytokine Release Syndrome in Large B-Cell Lymphoma Patients Receiving Epcoritamab Monotherapy

Catherine Thieblemont, Yasmin H. Karimi, Chan Y Cheah, Michael Roost Clausen, Kim Linton, Tycel J. Phillips, Franck Morschhauser, Martin Hutchings, Rebekah Conlon, Saurabh Mukhopadhyay, Aurelie Le Maitre, Yu Deng, Mariana Sacchi, Thomas Doerr, Minh Dinh, William Palo, Loretta Nastoupil
Journal: Blood
Blood (2024) 144 (Supplement 1): 4491.
https://doi.org/10.1182/blood-2024-200957
Published: 2024
Journal Articles

Cell-Intrinsic and Immune-Mediated Effects in Lymphoma Patients Treated with Golcadomide and Associations with Treatment Outcome

Soraya Carrancio, Jessica Voetsch, Alberto Risueño, Carla Guarinos, Siddhesh Kulkarni, Mandeep Takhar, Matthew E. Stokes, Bérengère de Moucheron, Laura Furman, Julio C. Chavez, Jean-Marie Michot, Loretta Nastoupil, Daniel W. Pierce, Danielle Greenawalt, Michael Pourdehnad
Journal: Blood
Blood (2024) 144 (Supplement 1): 3104.
https://doi.org/10.1182/blood-2024-203139
Published: 2024
Journal Articles

Clinical Outcomes of Patients with High-Risk Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 ELARA 4-Year Update

Catherine Thieblemont, Martin Dreyling, Michael J. Dickinson, Joaquín Martínez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie L. Popplewell, Julio C. Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A. Riedell, Phoebe Joy Ho, Jose Antonio Pérez-Simón, Andy Chen, Loretta Nastoupil, Bastian von Tresckow, Andrés José María Ferreri, Takanori Teshima, Piers E.M. Patten, Joseph P. McGuirk, Fritz Offner, Andreas Viardot, Pier Luigi Zinzani, Ram Malladi, Aiesha Zia, Rakesh Awasthi, Davide Germano, Roberto Javier Ramos, Pei Hsu, Stephen J. Schuster, Nathan H. Fowler
Journal: Blood
Blood (2024) 144 (Supplement 1): 3034.
https://doi.org/10.1182/blood-2024-201730
Published: 2024
Journal Articles

Outcomes in Early Relapse of Follicular Lymphoma Versus Early Histologic Transformation Following Firstline Immunochemotherapy in Follicular Lymphoma

Carla Casulo, Melissa C. Larson, Jonathan R Day, Urshila Durani, Mazie Tsang, Jonathan W. Friedberg, Grzegorz S. Nowakowski, Jean L. Koff, Dai Chihara, Richard Burack, Thomas M. Habermann, Loretta Nastoupil, Izidore S. Lossos, Peter Martin, Matthew Holets, Brad S. Kahl, Jonathan J. Cohen, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 1652.
https://doi.org/10.1182/blood-2024-201078
Published: 2024
Journal Articles

Efficacy and Safety Outcomes of CAR T-Cell Therapies in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Who Received Prior Treatment with Mosunetuzumab

Adam Braun, Stephen J. Schuster, Loretta Nastoupil, Nancy L. Bartlett, Mazyar Shadman, Anita Kumar, Dimitrios Tzachanis, Dai Chihara, Mei Wu, Michael C. Wei, Shen Yin, Jing Qi Hao, Qian Zhu, Yong Mun, L. Elizabeth Budde
Journal: Blood
Blood (2024) 144 (Supplement 1): 6555.
https://doi.org/10.1182/blood-2024-198409
Published: 2024
Journal Articles

Understanding the Patient Perspective on Treatment Preferences for Follicular Lymphoma

Mazie Tsang, Urshila Durani, Jonathan R Day, Melissa C. Larson, Matthew Holets, Kathleen J Yost, Jonathon B. Cohen, Jonathan W. Friedberg, Izidore S. Lossos, Peter Martin, Brad S. Kahl, Thomas M. Habermann, Loretta Nastoupil, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Carla Casulo, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 7598.
https://doi.org/10.1182/blood-2024-210968
Published: 2024
Journal Articles

Longer Follow-up of Golcadomide (GOLCA), a Cereblon E3 Ligase Modulator (CELMoD™) Agent ± Rituximab (RTX), in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Jean-Marie Michot, Franck Morschhauser, Silvia Ferrari, Judit Mészáros Jørgensen, Loretta Nastoupil, Emmanuel Bachy, Michael Pourdehnad, Akshay Sudhindra, Alev Akyol, Bérengère de Moucheron, Soraya Carrancio, Jessica Voetsch, Xirong Zheng, Julio C. Chavez
Journal: Blood
Blood (2024) 144 (Supplement 1): 869.
https://doi.org/10.1182/blood-2024-203163
Published: 2024